D.B. Root & Company LLC Sells 57 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

D.B. Root & Company LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 780 shares of the medical equipment provider’s stock after selling 57 shares during the period. D.B. Root & Company LLC’s holdings in Intuitive Surgical were worth $407,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in ISRG. LVW Advisors LLC raised its holdings in shares of Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. boosted its position in shares of Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after buying an additional 19 shares during the last quarter. Hazlett Burt & Watson Inc. boosted its holdings in Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after acquiring an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. raised its holdings in shares of Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the last quarter. Finally, Fragasso Financial Advisors Inc lifted its position in shares of Intuitive Surgical by 3.0% during the fourth quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after purchasing an additional 20 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Activity

In related news, CFO Jamie Samath sold 108 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 1,012 shares of the business’s stock in a transaction on Friday, October 25th. The shares were sold at an average price of $514.00, for a total transaction of $520,168.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,830,084. This represents a 15.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,487 shares of company stock worth $22,590,975 over the last three months. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $610.45 on Thursday. The company has a 50 day simple moving average of $544.61 and a two-hundred day simple moving average of $502.64. The company has a market capitalization of $217.43 billion, a price-to-earnings ratio of 98.14, a P/E/G ratio of 5.13 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $614.72.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on ISRG. Stifel Nicolaus increased their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Leerink Partners lifted their target price on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Truist Financial increased their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. Mizuho lifted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Citigroup boosted their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.